vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Life360, Inc. (LIF). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $146.0M, roughly 1.3× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 0.9%, a 87.9% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 23.7%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $16.0M). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 29.5%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
FOLD vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $146.0M |
| Net Profit | $1.7M | $129.7M |
| Gross Margin | 85.7% | 75.1% |
| Operating Margin | 8.6% | 6.1% |
| Net Margin | 0.9% | 88.8% |
| Revenue YoY | 23.7% | 26.4% |
| Net Profit YoY | -88.5% | 1425.9% |
| EPS (diluted) | $0.00 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $146.0M | ||
| Q3 25 | $169.1M | $124.5M | ||
| Q2 25 | $154.7M | $115.4M | ||
| Q1 25 | $125.2M | $103.6M | ||
| Q4 24 | $149.7M | $115.5M | ||
| Q3 24 | $141.5M | $92.9M | ||
| Q2 24 | $126.7M | $84.9M | ||
| Q1 24 | $110.4M | $78.2M |
| Q4 25 | $1.7M | $129.7M | ||
| Q3 25 | $17.3M | $9.8M | ||
| Q2 25 | $-24.4M | $7.0M | ||
| Q1 25 | $-21.7M | $4.4M | ||
| Q4 24 | $14.7M | $8.5M | ||
| Q3 24 | $-6.7M | $7.7M | ||
| Q2 24 | $-15.7M | $-11.0M | ||
| Q1 24 | $-48.4M | $-9.8M |
| Q4 25 | 85.7% | 75.1% | ||
| Q3 25 | 88.5% | 78.0% | ||
| Q2 25 | 90.2% | 78.4% | ||
| Q1 25 | 90.7% | 80.6% | ||
| Q4 24 | 90.1% | 74.0% | ||
| Q3 24 | 90.6% | 75.4% | ||
| Q2 24 | 91.1% | 75.0% | ||
| Q1 24 | 87.7% | 76.7% |
| Q4 25 | 8.6% | 6.1% | ||
| Q3 25 | 20.3% | 4.6% | ||
| Q2 25 | -6.1% | 1.7% | ||
| Q1 25 | -6.3% | 2.1% | ||
| Q4 24 | 10.7% | 4.9% | ||
| Q3 24 | 15.3% | -5.3% | ||
| Q2 24 | 11.8% | -2.8% | ||
| Q1 24 | -25.1% | -8.2% |
| Q4 25 | 0.9% | 88.8% | ||
| Q3 25 | 10.2% | 7.9% | ||
| Q2 25 | -15.8% | 6.1% | ||
| Q1 25 | -17.3% | 4.2% | ||
| Q4 24 | 9.8% | 7.4% | ||
| Q3 24 | -4.8% | 8.3% | ||
| Q2 24 | -12.4% | -12.9% | ||
| Q1 24 | -43.9% | -12.5% |
| Q4 25 | $0.00 | $1.53 | ||
| Q3 25 | $0.06 | $0.11 | ||
| Q2 25 | $-0.08 | $0.08 | ||
| Q1 25 | $-0.07 | $0.05 | ||
| Q4 24 | $0.05 | $0.14 | ||
| Q3 24 | $-0.02 | $0.09 | ||
| Q2 24 | $-0.05 | $-0.15 | ||
| Q1 24 | $-0.16 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $494.3M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $548.2M |
| Total Assets | $949.9M | $959.7M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $494.3M | ||
| Q3 25 | $263.8M | $455.7M | ||
| Q2 25 | $231.0M | $432.7M | ||
| Q1 25 | $250.6M | $168.9M | ||
| Q4 24 | $249.9M | $159.2M | ||
| Q3 24 | $249.8M | $159.0M | ||
| Q2 24 | $260.1M | $160.8M | ||
| Q1 24 | $239.6M | $73.4M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | $5.2M |
| Q4 25 | $274.2M | $548.2M | ||
| Q3 25 | $230.4M | $391.4M | ||
| Q2 25 | $204.3M | $366.7M | ||
| Q1 25 | $193.6M | $376.3M | ||
| Q4 24 | $194.0M | $358.5M | ||
| Q3 24 | $178.8M | $339.7M | ||
| Q2 24 | $132.5M | $326.7M | ||
| Q1 24 | $130.7M | $239.8M |
| Q4 25 | $949.9M | $959.7M | ||
| Q3 25 | $868.8M | $787.5M | ||
| Q2 25 | $815.3M | $753.6M | ||
| Q1 25 | $789.8M | $455.4M | ||
| Q4 24 | $785.0M | $441.6M | ||
| Q3 24 | $786.6M | $427.4M | ||
| Q2 24 | $749.5M | $405.9M | ||
| Q1 24 | $721.8M | $318.8M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $36.8M |
| Free Cash FlowOCF − Capex | $16.0M | $36.6M |
| FCF MarginFCF / Revenue | 8.6% | 25.1% |
| Capex IntensityCapex / Revenue | 0.2% | 0.2% |
| Cash ConversionOCF / Net Profit | 9.62× | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $36.8M | ||
| Q3 25 | $35.7M | $26.4M | ||
| Q2 25 | $-26.5M | $13.3M | ||
| Q1 25 | $7.8M | $12.1M | ||
| Q4 24 | $-3.9M | $12.3M | ||
| Q3 24 | $-23.0M | $6.3M | ||
| Q2 24 | $22.7M | $3.3M | ||
| Q1 24 | $-29.7M | $10.7M |
| Q4 25 | $16.0M | $36.6M | ||
| Q3 25 | $35.3M | $25.6M | ||
| Q2 25 | $-28.9M | $12.7M | ||
| Q1 25 | $7.5M | $11.9M | ||
| Q4 24 | $-4.2M | $11.2M | ||
| Q3 24 | $-23.3M | $6.3M | ||
| Q2 24 | $21.6M | $3.2M | ||
| Q1 24 | $-31.5M | — |
| Q4 25 | 8.6% | 25.1% | ||
| Q3 25 | 20.9% | 20.6% | ||
| Q2 25 | -18.7% | 11.0% | ||
| Q1 25 | 6.0% | 11.5% | ||
| Q4 24 | -2.8% | 9.7% | ||
| Q3 24 | -16.5% | 6.8% | ||
| Q2 24 | 17.0% | 3.8% | ||
| Q1 24 | -28.5% | — |
| Q4 25 | 0.2% | 0.2% | ||
| Q3 25 | 0.2% | 0.6% | ||
| Q2 25 | 1.6% | 0.6% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 0.2% | 1.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.9% | 0.1% | ||
| Q1 24 | 1.6% | 0.0% |
| Q4 25 | 9.62× | 0.28× | ||
| Q3 25 | 2.06× | 2.70× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | -0.27× | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
LIF
Segment breakdown not available.
